Secondary Central Nervous System Lymphoma (SCNSL)
Also known as: Secondary Central Nervous System Lymphoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB09053 | Ibrutinib | 1 | Active Not Recruiting | 1 |
DB00480 | Lenalidomide | 1 | Active Not Recruiting | 1 |
DB00073 | Rituximab | 1 | Active Not Recruiting | 1 |
DB11703 | Acalabrutinib | 1 / 2 | Recruiting | 1 |
DB00480 | Lenalidomide | 1 / 2 | Recruiting | 1 |
DB15044 | Tafasitamab | 1 / 2 | Recruiting | 1 |
DB00135 | Tyrosine | 1 / 2 | Recruiting | 1 |
DB00987 | Cytarabine | 2 | Active Not Recruiting | 1 |
DB09053 | Ibrutinib | 2 | Active Not Recruiting | 1 |
DB11633 | Isavuconazole | 2 | Active Not Recruiting | 1 |
DB00563 | Methotrexate | 2 | Active Not Recruiting | 1 |
DB00563 | Methotrexate | 2 | Recruiting | 1 |
DB00642 | Pemetrexed | 2 | Recruiting | 1 |
DB00073 | Rituximab | 2 | Recruiting | 1 |
DB15035 | Zanubrutinib | 2 | Recruiting | 2 |